311 related articles for article (PubMed ID: 12106588)
1. Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.
Katofiasc MA; Nissen J; Audia JE; Thor KB
Life Sci; 2002 Aug; 71(11):1227-36. PubMed ID: 12106588
[TBL] [Abstract][Full Text] [Related]
2. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat.
Thor KB; Katofiasc MA
J Pharmacol Exp Ther; 1995 Aug; 274(2):1014-24. PubMed ID: 7636716
[TBL] [Abstract][Full Text] [Related]
3. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
Jones CK; Eastwood BJ; Need AB; Shannon HE
Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
[TBL] [Abstract][Full Text] [Related]
4. Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats.
Miyazato M; Kaiho Y; Kamo I; Chancellor MB; Sugaya K; de Groat WC; Yoshimura N
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F264-71. PubMed ID: 18480175
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
Koch S; Hemrick-Luecke SK; Thompson LK; Evans DC; Threlkeld PG; Nelson DL; Perry KW; Bymaster FP
Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Iyengar S; Webster AA; Hemrick-Luecke SK; Xu JY; Simmons RM
J Pharmacol Exp Ther; 2004 Nov; 311(2):576-84. PubMed ID: 15254142
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
Jost W; Marsalek P
Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
Beyer CE; Boikess S; Luo B; Dawson LA
J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor.
Engleman EA; Perry KW; Mayle DA; Wong DT
Neuropsychopharmacology; 1995 Jul; 12(4):287-95. PubMed ID: 7576005
[TBL] [Abstract][Full Text] [Related]
10. [Duloxetine and other tricyclic antidepressive agents: pharmacodynamic effects in the lower urinary tract].
Vela Navarrete R; Pérez Martínez FC; Ramírez Pérez del Yerro M; Cabrera Pérez J; González Enguita C
Actas Urol Esp; 2004 Mar; 28(3):252. PubMed ID: 15141426
[No Abstract] [Full Text] [Related]
11. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
Bymaster FP; Dreshfield-Ahmad LJ; Threlkeld PG; Shaw JL; Thompson L; Nelson DL; Hemrick-Luecke SK; Wong DT
Neuropsychopharmacology; 2001 Dec; 25(6):871-80. PubMed ID: 11750180
[TBL] [Abstract][Full Text] [Related]
12. Stability of the acetic acid-induced bladder irritation model in alpha chloralose-anesthetized female cats.
Kullmann FA; Wells GI; Langdale CL; Zheng J; Thor KB
PLoS One; 2013; 8(9):e73771. PubMed ID: 24040064
[TBL] [Abstract][Full Text] [Related]
13. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms for the inhibition of genital vascular responses by antidepressants in a female rabbit model.
Angulo J; Cuevas P; Cuevas B; Gupta S; Sáenz de Tejada I
J Pharmacol Exp Ther; 2004 Jul; 310(1):141-9. PubMed ID: 15034084
[TBL] [Abstract][Full Text] [Related]
15. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats.
Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
J Neurochem; 1997 Dec; 69(6):2616-9. PubMed ID: 9375697
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of clomipramine and duloxetine on detrusor and striated sphincter function in male and female rabbits.
Pérez Martínez FC; Vela Navarrete R; Castilla Reparaz C
Arch Esp Urol; 2006 Oct; 59(8):839-48. PubMed ID: 17153510
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of bladder overactivity by duloxetine in combination with foot stimulation or WAY-100635 treatment in cats.
Schwen Z; Matsuta Y; Shen B; Wang J; Roppolo JR; de Groat WC; Tai C
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1663-8. PubMed ID: 24154699
[TBL] [Abstract][Full Text] [Related]
18. The role of 5-HT(1A) receptors in control of lower urinary tract function in cats.
Thor KB; Katofiasc MA; Danuser H; Springer J; Schaus JM
Brain Res; 2002 Aug; 946(2):290-7. PubMed ID: 12137933
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain.
Kasamo K; Blier P; De Montigny C
J Pharmacol Exp Ther; 1996 Apr; 277(1):278-86. PubMed ID: 8613930
[TBL] [Abstract][Full Text] [Related]
20. Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.
Thor KB
Urology; 2003 Oct; 62(4 Suppl 1):3-9. PubMed ID: 14550831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
